These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 4139403)

  • 1. Intensive immunosuppression in the treatment of multiple sclerosis.
    Ring J; Seifert J; Lob G; Coulin K; Angstwurm H; Frick E; Brass B; Mertin J; Backmund H; Brendel W
    Lancet; 1974 Nov; 2(7889):1093-6. PubMed ID: 4139403
    [No Abstract]   [Full Text] [Related]  

  • 2. Allergic reactions to a horse globulin therapy and their prevention by induction of immunological tolerance.
    Ring J; Seifert J; Lob G; Hopf U; Land W; Brendel W
    Allergol Immunopathol (Madr); 1974; 2(2):93-8. PubMed ID: 4211785
    [No Abstract]   [Full Text] [Related]  

  • 3. [Serologic studies of patients under treatment with xenogenous antilymphocyte globulin].
    Hopf U; Fateh-Moghadam A; Land W; Brendel W
    Klin Wochenschr; 1970 Aug; 48(15):906-13. PubMed ID: 4996980
    [No Abstract]   [Full Text] [Related]  

  • 4. Reactivities to horse anti-lymphocyte globulin. I. Induction of immunologic tolerance in man.
    Gewurz H; Moberg A; Simmons R; Pollara B; Soll R; Najarian S
    Int Arch Allergy Appl Immunol; 1970; 39(2-3):113-20. PubMed ID: 4990554
    [No Abstract]   [Full Text] [Related]  

  • 5. [Attempt for an induction of immune tolerance against horse IgG in men].
    Land W; Brendel W; Hopf U; Seifert J
    Klin Wochenschr; 1970 Feb; 48(4):241-4. PubMed ID: 5523317
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunosuppressive treatment of multiple sclerosis].
    Frick E
    Nervenarzt; 1976 Jul; 47(7):424-8. PubMed ID: 958545
    [No Abstract]   [Full Text] [Related]  

  • 7. Intensive immunosuppression in patients with disseminated sclerosis. II. Tolerance to equine IgG and effect on immunoglobulin and complement levels.
    Jones VE; Lance EM; Abbosh J; Graves HE
    Clin Exp Immunol; 1975 Jul; 21(1):13-22. PubMed ID: 810281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of 'maximum immune suppression' with thoracic duct drainage, ALG, azathioprine and cortisone in some neurological disorders.
    Brendel W; Seifert J; Lob G
    Proc R Soc Med; 1972 Jun; 65(6):531-5. PubMed ID: 5035906
    [No Abstract]   [Full Text] [Related]  

  • 9. [Induction of tolerance of heterologous protein in therapy with antilymphocytic globulin in man].
    Tilz GP
    Med Klin; 1972 Mar; 67(12):410-3. PubMed ID: 4112374
    [No Abstract]   [Full Text] [Related]  

  • 10. Intensive immunosuppression in patients with disseminated sclerosis. I. Clinical response.
    Lance EM; Kremer M; Abbosh J; Jones VE; Knight S; Medawar PB
    Clin Exp Immunol; 1975 Jul; 21(1):1-12. PubMed ID: 1237376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunosuppressive treatment of multiple sclerosis. 3. Results of treatment with azathioprine and antilymphocytic globulin (author's transl)].
    Frick E; Angstwurm H; Strauss G
    MMW Munch Med Wochenschr; 1974 Nov; 116(48):2105-12. PubMed ID: 4216823
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatic allotransplantation in the baboon. 3. The effects of immunosuppression and administration of donor-specific antigen after transplantation.
    Myburgh JA; Smit JA; Mieny CJ; Mason JA
    Transplantation; 1971 Sep; 12(3):202-10. PubMed ID: 4105459
    [No Abstract]   [Full Text] [Related]  

  • 13. The clinical use of antilymphocyte globulin.
    Najarian JS; Simmons RL
    N Engl J Med; 1971 Jul; 285(3):158-66. PubMed ID: 4103453
    [No Abstract]   [Full Text] [Related]  

  • 14. Induction of immunologic tolerance to antilymphocyte globulin in man.
    Gewurz H; Moberg AW; Simmons RL; Pollara B; Gunnarsson A; Soll R; Najarian JS
    Surg Forum; 1969; 20():259-61. PubMed ID: 4986402
    [No Abstract]   [Full Text] [Related]  

  • 15. Further studies on antihuman thymocyte IgG. Antibody specificities, opsonin activity correlated to immunosuppression, lymphopenia, and hyporesponsiveness to horse IgG in primates.
    Svehag SE; Haxner P; Manhem L; Balner H; Sundqvist K; Schilling W
    Transplantation; 1972 Jul; 14(1):21-8. PubMed ID: 4624718
    [No Abstract]   [Full Text] [Related]  

  • 16. Double-blind, controlled trial of immunosuppression in treatment of multiple sclerosis.
    Mertin J; Knight SC; Rudge P; Thompson EJ; Healy MJ
    Lancet; 1980 Nov; 2(8201):949-51. PubMed ID: 6107592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihuman lymphoblast globulin.
    Najarian JS; Simmons RL; Gewurz H; Moberg A; Merkel F; Moore GE
    Fed Proc; 1970; 29(1):197-201. PubMed ID: 4189495
    [No Abstract]   [Full Text] [Related]  

  • 18. Toleracne to equine IgG after immunosuppression in patients with multiple sclerosis.
    Jones VE; Lance EM; Abbosh J; Graves HE
    Postgrad Med J; 1976; 52(5 Suppl):136-8. PubMed ID: 1033536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind controlled trial of immunosuppression in the treatment of multiple sclerosis: final report.
    Mertin J; Rudge P; Kremer M; Healey MJ; Knight SC; Compston A; Batchelor JR; Thompson EJ; Halliday AM; Denman M; Medawar PB
    Lancet; 1982 Aug; 2(8294):351-4. PubMed ID: 6124759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proceedings: Immunosuppressive treatment of multiple sclerosis with ALG and/or thoracic duct drainage.
    Brendel W; Ring J; Seifert J
    Neurology; 1975 May; 25(5):490. PubMed ID: 1169712
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.